Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25,724
Closed -$1.74M 528
2025
Q3
$1.74M Buy
25,724
+13,444
+109% +$892K 0.03% 225
2025
Q2
$800K Buy
12,280
+4,371
+55% +$262K 0.01% 318
2025
Q1
$489K Buy
7,909
+759
+11% +$50.3K 0.01% 419
2024
Q4
$515K Buy
7,150
+293
+4% +$22.9K 0.01% 410
2024
Q3
$559K Sell
6,857
-335,450
-98% -$26.8M 0.01% 383
2024
Q2
$25.4M Buy
+342,307
New +$25.7M 0.46% 62

Other funds holding HOLX

J. Safra Sarasin Holding's HOLX Position: Q4 2025 in Review

J. Safra Sarasin Holding sold out of Hologic (HOLX) in Q4 2025, closing a stake of 25,724 shares — an estimated $1.74M sold.

J. Safra Sarasin Holding first reported a position in HOLX in Q2 2024 and held it in 6 quarters. The position peaked at $25.4M in Q2 2024. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • J. Safra Sarasin Holding reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
  • J. Safra Sarasin Holding sold 25,724 Hologic shares in Q4 2025, an estimated $1.74M.
  • J. Safra Sarasin Holding first reported a position in Hologic in Q2 2024 and held it in 6 quarters.
  • J. Safra Sarasin Holding's Hologic position peaked at $25.4M in Q2 2024.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on J. Safra Sarasin Holding's 13F filing for Q4 2025, filed 15 Jan 2026.